Home › Coronary Artery Disease › Oklahoma
Coronary Artery Disease clinical trials in Oklahoma
7 studies for Coronary Artery Disease are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Oklahoma Heart Hillcrest Medical, Tulsa
Recruiting
Ages 18 to 90 · All sexes · Updated Sep 30, 2026 · NCT07296744Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- South Oklahoma Heart Research, LLC, Oklahoma City
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- Oklahoma City VA Medical Center, Oklahoma City
- Oklahoma Heart Institute at Hillcrest Medical Center, Tulsa
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT02061436MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 11, 2025 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Oklahoma Heart, Oklahoma City
Recruiting
All ages · All sexes · Updated Jul 24, 2025 · NCT04634240MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Recruiting
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.